Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Abhishek D. Garg

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number1703449
Number of pages23
JournalOncoImmunology
Volume9
Issue number1
DOIs
Publication statusPublished - 2020

Keywords

  • Antigen-presenting cell
  • autophagy
  • cytotoxic T lymphocyte
  • endoplasmic reticulum stress
  • CAR T cells
  • cytokines
  • chemokines
  • dendritic cell
  • immune checkpoint blocker
  • type I interferon
  • CD8(+) T-CELLS
  • RANDOMIZED PHASE-2 TRIAL
  • BREAST-CANCER PATIENTS
  • SOFT-TISSUE SARCOMA
  • FIND-ME SIGNAL
  • DENDRITIC CELLS
  • CHECKPOINT BLOCKADE
  • APOPTOTIC CELLS
  • CALRETICULIN EXPOSURE
  • ANTITUMOR IMMUNITY

Cite this

Vanmeerbeek, I., Sprooten, J., De Ruysscher, D., Tejpar, S., Vandenberghe, P., Fucikova, J., Spisek, R., Zitvogel, L., Kroemer, G., Galluzzi, L., & Garg, A. D. (2020). Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology , 9(1), [1703449]. https://doi.org/10.1080/2162402X.2019.1703449